document
infecti
agent
blood
smear
cytolog
examin
requir
skill
personnel
time
consum
adequ
blood
film
examin
take
minut
lack
sensit
pathogen
fals
posit
also
occur
stain
artifact
confus
therefor
cytolog
examin
blood
smear
recommend
sole
mean
screen
blood
donor
infect
posit
blood
cultur
result
indic
presenc
cultiv
bacteria
blood
although
transient
bacteremia
occur
healthi
anim
disrupt
mucos
barrier
transfus
blood
anim
transient
bacteremia
document
caus
diseas
recipi
therefor
routin
blood
cultur
gener
indic
screen
potenti
blood
donor
rare
except
see
bartonella
section
transfus
medicin
routin
blood
cultur
appropri
screen
individu
unit
blood
bacteria
contamin
suspect
assay
detect
antigen
sever
pathogen
whole
blood
serum
commerci
avail
dirofilaria
immiti
dog
cat
felin
leukemia
viru
felv
antigen
test
use
frequent
donor
screen
health
assess
test
avail
organ
potenti
inaccur
result
oper
error
small
immun
system
gener
clear
nonviabl
microb
quickli
amplif
specif
microbi
nucleic
acid
use
assay
like
polymeras
chain
reaction
pcr
gener
indic
presenc
viabl
microb
provid
laboratori
qualiti
assur
high
techniqu
provid
high
analyt
sensit
specif
potenti
rapidli
test
pathogen
disadvantag
includ
current
lack
nucleic
assay
veterinari
medicin
lack
standard
assay
among
laboratori
result
variabl
sensit
specif
lack
assay
avail
infecti
agent
expens
also
high
analyt
sensit
pcr
assay
necessarili
impli
high
clinic
sensit
word
assay
may
detect
minut
quantiti
dna
laboratori
poor
sensit
detect
pathogen
blood
specimen
pcr
assay
util
blood
anim
receiv
time
volum
transfus
although
molecular
assay
high
analyt
sensit
assay
amplifi
microb
specimen
collect
thu
fals
neg
result
occur
agent
found
low
quantiti
bloodstream
ehrlichia
cani
felin
immunodefici
viru
fiv
anim
overt
microscop
evid
infect
posit
pcr
assay
clinic
relev
pathogen
exclud
donor
pool
whether
pathogen
caus
chronic
persist
infect
elimin
antimicrobi
therapi
certain
anim
histori
previou
posit
test
result
pathogen
use
blood
donor
posit
serum
antibodi
assay
result
suggest
previou
infect
pathogen
question
prove
current
infect
neg
result
antibodi
test
gener
suggest
lack
infect
serum
antibodi
undetect
even
presenc
activ
infect
situat
like
common
antibodi
test
perform
acut
stage
infect
well
document
sever
pathogen
see
ehrlichia
anaplasma
section
agent
bartonella
stealth
organ
evad
immun
system
may
induc
detect
serum
antibodi
sever
immunocompromis
anim
also
may
fail
mount
specif
antibodi
respons
eg
cat
advanc
fiv
infect
dog
cat
gener
ill
hope
would
exclud
donor
pool
base
find
assay
avail
detect
antibodi
respons
pathogen
advantag
rapid
inexpens
potenti
oper
error
assay
small
standard
serolog
test
offer
commerci
laboratori
infecti
agent
avail
differ
antigen
antigen
prepar
reagent
protocol
influenc
result
serolog
assay
among
laboratori
assay
addit
inher
subject
interpret
immunofluoresc
antibodi
ifa
assay
problemat
pathogen
combin
serolog
organ
demonstr
techniqu
cytolog
cultur
pcr
may
requir
maxim
diagnosi
dirofilaria
immiti
meet
criteria
use
categor
pathogen
transfus
microfilaria
infect
donor
lead
heartworm
diseas
recipi
howev
filarem
blood
transfus
recipi
potenti
interfer
diagnost
test
infecti
mosquito
vector
carri
wolbachia
addit
donor
infect
immiti
would
consid
healthi
donor
collect
larg
amount
blood
donor
could
unsaf
therefor
recommend
dog
cat
use
blood
donor
heartworm
endem
area
screen
immiti
infect
place
heartworm
prophylaxi
anaplasma
spp
phagocytophilum
plati
caus
agent
canin
granulocyt
anaplasmosi
infecti
canin
cyclic
thrombocytopenia
respect
transmiss
phagocytophilum
occur
via
ixod
scapulari
ixod
pacificu
tick
unit
state
widespread
subclin
infect
follow
pathogen
clearanc
appear
common
human
dog
pathway
transmiss
via
infect
blood
either
experiment
blood
human
medicin
sever
report
phagocytophilum
via
differ
blood
product
rbc
leukoreduc
platelet
also
granulocyt
anaplasmosi
widespread
subclin
infect
follow
pathogen
clearanc
appear
common
human
dog
immunocompromis
elderli
peopl
infect
caus
sever
diseas
donat
screen
inactiv
pathogen
reduct
technolog
consid
human
anaplasmosi
occur
splenectom
dog
chemotherapi
pack
rbc
transfus
donor
recipi
test
posit
pcr
kohn
unpublish
data
pcr
posit
dog
seroneg
clinic
hematolog
variabl
within
refer
antibodi
anaplasma
speci
detect
use
ifa
assay
autom
system
later
flow
elisa
elisa
serolog
among
anaplasma
speci
occur
assay
tabl
seropreval
ifa
elisa
high
endem
area
antibodi
titer
may
persist
sever
month
even
extent
phagocytophilum
persist
tissu
contribut
chronic
diseas
manifest
human
dog
current
unknown
studi
treatment
experiment
infect
dog
prednisolon
month
infect
follow
develop
posit
pcr
result
organ
dog
thrombocytopenia
reappear
morula
blood
anoth
studi
dog
infect
phagocytophilum
exposur
ixod
scapulari
tick
pcr
posit
least
light
inform
panel
recommend
optim
standard
screen
donor
use
serolog
pcr
dog
test
posit
assay
exclud
exclus
seroposit
dog
might
limit
donor
pool
endem
area
see
comment
tabl
anaplasma
plati
thought
transmit
rhipicephalu
sanguineu
infect
common
region
endem
tick
anaplasma
plati
establish
chronic
persist
subclin
infect
sometim
accompani
mild
dog
infect
experiment
blood
develop
sever
thrombocytopenia
within
day
infect
diseas
report
neither
human
dog
ifa
assay
detect
serum
antibodi
commerci
avail
occur
pcr
test
blood
sampl
diagnost
method
choic
assay
phagocytophilum
antibodi
may
may
detect
plati
antibodi
tabl
donor
dog
neg
antibodi
neg
use
pcr
optim
tabl
babesiosi
caus
organ
genu
babesia
babesia
cani
voge
babesia
gibsoni
common
speci
diagnos
north
american
dog
sever
babesia
spp
identifi
dog
north
america
babesia
sp
coco
babesia
conrada
part
world
b
cani
b
rossi
b
babesia
sp
transmiss
babesia
spp
transfus
well
document
result
diseas
dog
peracut
acut
chronic
subclin
high
seropreval
b
cani
occur
increas
preval
b
gibsoni
occur
american
pit
bull
terrier
american
staffordshir
terrier
detect
optim
screen
includ
serolog
b
voge
b
gibsoni
broad
rang
pcr
screen
ie
detect
known
babesia
spp
infect
dog
minim
screen
may
includ
pcr
screen
pit
bull
type
dog
greyhound
dog
known
tick
exposur
dog
bite
exposur
pit
bull
type
dog
addit
pcr
screen
consid
beyond
optim
recommend
enhanc
sensit
dog
infect
sever
bartonella
spp
proven
suspect
vector
flea
potenti
bartonella
vinsonii
subspeci
berkhoffi
b
rochalima
common
speci
amplifi
dog
flea
shelter
bartonella
hensela
common
cat
blood
ctenocephalid
feli
collect
cat
also
grown
amplifi
blood
although
bartonella
spp
transmiss
document
blood
transfus
dog
clinic
ill
dog
posit
bartonella
spp
detect
healthi
dog
harbor
bartonella
spp
organ
transmit
thu
plausibl
bartonella
spp
could
transmit
blood
transfus
result
clinic
ill
panel
therefor
believ
test
indic
genu
valid
serolog
assay
pcr
assay
cultur
avail
b
hensela
b
vinsonii
subspeci
berkhoffi
like
pathogen
dog
tabl
sensit
way
document
bartonella
spp
blood
dog
concurr
use
special
cultur
media
bartonella
alpha
proteobacteria
growth
medium
bapgm
pcr
assay
multipl
blood
sampl
combin
test
detect
known
bartonella
spp
howev
neg
even
infect
dog
sampl
test
panel
believ
optim
standard
use
b
hensela
b
vinsonii
subspeci
berkhoffi
seroneg
neg
dog
donor
tabl
canin
blood
donor
candid
studi
although
screen
dog
posit
bartonella
spp
addit
serolog
variabl
among
bartonella
spp
assay
routin
avail
speci
thu
panel
believ
bartonella
spp
serum
antibodi
test
alon
use
exclus
assess
dog
use
blood
donor
sever
laboratori
offer
broad
rang
pcr
assay
amplifi
dna
multipl
bartonella
spp
offer
specif
primer
b
hensela
b
vinsonii
subspeci
berkhoffi
tabl
test
serolog
bapgm
practic
expens
turnaround
time
panel
believ
minim
standard
use
dog
pcr
neg
dna
b
hensela
b
vinsonii
subspeci
berkhoffi
ehrlichia
cani
e
ewingii
e
chaffeensi
agent
belong
famili
rickettsiacea
capabl
caus
diseas
dog
pathogen
e
cani
greatest
import
blood
donor
screen
high
preval
worldwid
propens
caus
chronic
persist
infect
recent
studi
suggest
e
ewingii
also
capabl
caus
persist
infect
restrict
geograph
distribut
experiment
sc
inocul
e
cani
result
infect
posit
blood
screen
potenti
donor
dog
antibodi
ehrlichia
antigen
perform
ifa
assay
sever
commerci
assaysb
variabl
serolog
occur
among
ehrlichia
speci
assay
recombin
peptid
antigen
e
cani
e
ewingii
combin
togeth
singl
spot
posit
result
reflect
either
seroreact
e
cani
e
ewingii
pathogen
sensit
specif
assay
compar
ifa
clinic
sensit
specif
avail
assay
requir
studi
serolog
reactiv
e
cani
e
ewingii
e
chaffeensi
variabl
known
assay
infect
document
pcr
assay
seroconvers
panel
believ
optim
standard
use
donor
seroneg
pcr
neg
tabl
import
e
cani
import
primari
pathogen
dog
infect
sever
hemoplasma
speci
includ
mycoplasma
haemocani
candidatu
haematoparvum
possibl
also
candidatu
haemominutum
relat
although
tick
implic
transmiss
haemocani
mechan
transmiss
proven
kennel
dog
research
anim
appear
higher
risk
infect
haemocani
diagnosi
infect
base
pcr
assay
whole
serolog
assay
hemoplasma
infect
commerci
avail
gener
dog
subclin
infect
organ
haemocani
caus
anemia
splenectom
dog
case
report
infect
dog
immunocompromis
comorbid
singl
clinic
infect
candidatu
haematoparvum
report
splenectom
dog
hemic
neoplasia
treat
chemotherapi
unclear
extent
hemoplasma
play
role
develop
dog
receiv
sever
unit
blood
product
test
posit
use
pcr
candidatu
haematoparvum
test
neg
transfus
syke
et
al
unpublish
data
therefor
optim
donor
dog
screen
hemoplasma
pcr
assay
exclud
posit
tabl
howev
learn
risk
transfus
blood
test
posit
candidatu
haemominutum
candidatu
haematoparvum
test
pathogen
could
consid
option
also
kept
mind
preval
hemoplasma
infect
gener
pet
dog
popul
north
america
appear
low
whether
viabil
canin
hemoplasma
speci
lost
storag
blood
product
see
felin
hemoplasma
requir
studi
antimicrobi
therapi
reliabl
elimin
hemoplasma
panel
recommend
treat
potenti
donor
antimicrobi
attempt
elimin
infect
hepatozoon
cani
hepatozoon
americanum
tickborn
protozo
pathogen
transmit
primarili
ingest
rhipicephalu
sanguineu
amblyomma
maculatum
tick
north
america
distribut
infect
primarili
limit
unit
state
occasion
h
americanum
infect
identifi
state
includ
washington
vermont
california
h
cani
infect
subclin
h
americanum
caus
lethargi
fever
locomotori
abnorm
hyperesthesia
nephropathi
organ
circul
peripher
blood
gamont
leukocyt
report
transmiss
blood
transfus
screen
could
consid
endem
area
use
specif
pcr
assay
h
cani
h
americanum
serolog
assay
routin
diagnost
purpos
avail
north
america
leishmaniosi
caus
protozo
organ
genu
leishmania
transmit
mediterranean
region
bite
infect
femal
sandfli
vector
north
america
known
lutzomyia
shannoni
highli
suspect
vector
unit
state
transmiss
also
viscer
leishmaniosi
caus
leishmania
donovani
consid
exot
diseas
dog
north
america
except
foxhound
popul
dog
north
america
also
acquir
infect
travel
foreign
countri
month
year
diagnosi
viscer
leishmaniosi
transmit
blood
transfus
dog
clinic
healthi
foxhound
blood
retrospect
studi
perform
serum
sampl
foxhound
canid
unit
state
report
seropreval
foxhound
randomli
select
domest
dog
wild
canid
infect
appear
endem
within
foxhound
north
america
screen
everi
potenti
blood
donor
necessari
howev
foxhound
dog
travel
histori
endem
countri
screen
leishmania
spp
infect
use
ifa
serolog
perform
reput
laboratori
ifa
serolog
may
lack
sensit
subclin
infect
foxhound
dog
live
travel
endem
area
found
seroneg
screen
addit
leishmania
ifa
assay
leishmania
spp
trypanosoma
although
dog
either
infect
exclud
blood
donor
leishmania
spp
seroposit
dog
evalu
presenc
specif
antibodi
cruzi
clinic
inform
dog
experiment
infect
n
risticii
antibodi
n
risticii
detect
pet
polymeras
chain
reaction
use
studi
identifi
n
risticii
obtain
blood
cultur
clinic
ill
document
transmiss
n
risticii
dog
blood
although
committe
believ
optim
dog
test
neorickettsia
risticii
infect
screen
also
accept
rickettsia
feli
member
spot
fever
group
rickettsia
dog
unit
state
agent
like
induc
serolog
cross
reactiv
r
rickettsii
assay
current
assum
agent
associ
ill
dog
studi
need
evid
dog
reservoir
r
feli
ctenocephalid
feli
collect
cat
unit
state
commonli
posit
r
feli
current
unknown
whether
transfus
larg
volum
blood
r
feli
carrier
dog
ill
dog
need
transfus
would
clinic
sequela
pcr
assay
way
current
prove
r
feli
infect
dog
although
panel
believ
optim
dog
test
r
feli
infect
screen
also
accept
tabl
american
trypanosomiasi
chaga
diseas
caus
trypanosoma
cruzi
hemoflagel
protozoan
transmiss
commonli
occur
bite
ingest
triatomin
bug
small
number
cruzi
infect
report
peopl
north
america
patient
immunocompromis
time
infect
donor
countri
cruzi
endem
south
central
america
food
drug
administr
recommend
present
human
blood
donor
ask
histori
chaga
diseas
addit
test
least
use
licens
screen
infect
dog
result
acut
chronic
myocard
dog
experiment
inocul
cruzi
parasitem
develop
transient
lymphadenopathi
survivor
acut
diseas
remain
subclin
infect
sever
month
chronic
myocard
develop
infect
character
detect
concentr
specif
antibodi
low
concentr
circul
dog
develop
trypanosomiasi
unit
state
resid
texa
southwestern
state
seropreval
studi
dog
shelter
divers
ecoregion
texa
transmiss
dog
blood
transfus
report
dog
histori
travel
endem
area
texa
new
mexico
arizona
southern
california
mexico
central
america
south
america
consid
serolog
screen
ifa
indirect
hemagglutin
assay
iha
elisa
immunochromatograph
dipstick
test
seroposit
donor
exclud
donor
pool
serolog
cruzi
leishmania
spp
pcr
assay
detect
cruzi
whole
blood
also
could
brucella
cani
zoonot
pathogen
bacterium
caus
brucellosi
dog
vener
transmiss
occur
breed
transmiss
follow
oronas
contact
vagin
discharg
abort
materi
urin
infect
dog
human
brucella
infect
document
transmiss
b
cani
blood
transfus
document
dog
howev
infect
associ
prolong
bacteremia
may
subclin
thu
potenti
transmiss
transfus
commerci
avail
result
obtain
minut
serolog
screen
potenti
donor
antibodi
use
rapid
slide
agglutin
test
rsat
initi
posit
dog
exclud
blood
donor
addit
confirmatori
diagnost
assay
perform
use
blood
cultur
pcr
whole
blood
tube
agglutin
test
agaros
gel
immunodiffus
test
elisa
test
singl
neg
rsat
suffici
neuter
donor
meet
optim
standard
rsat
screen
repeat
sexual
activ
intact
dog
approach
support
numer
studi
conclud
rsat
highli
sensit
lack
recent
studi
pcr
assay
perform
whole
blood
genitourinari
secret
found
sensit
serolog
test
notabl
earli
phase
lyme
borreliosi
caus
spirochet
borrelia
burgdorferi
vector
ixod
mani
dog
northeastern
upper
midwest
region
unit
state
seroposit
small
percentag
dog
develop
polyarthr
infect
report
despit
abil
cultur
b
burgdorferi
human
studi
human
demonstr
risk
acquir
lyme
diseas
transfus
unit
pack
red
blood
cell
platelet
studi
dog
blood
sampl
experiment
infect
dog
test
posit
b
burgdorferi
consensu
panel
healthi
canin
blood
donor
screen
b
burgdorferi
screen
testa
b
detect
seroreact
pathogen
use
donor
seroposit
b
burgdorferi
anim
need
exclud
donor
pool
test
blood
donor
dog
n
helminthoeca
recommend
pathogen
produc
acut
diseas
without
evid
carrier
state
healthi
dog
without
evid
rocki
mountain
spot
fever
rmsf
caus
rickettsia
rickettsii
acut
system
infect
vascular
endotheli
cell
organ
rapidli
elimin
dog
surviv
clinic
ill
chronic
carrier
state
report
consensu
panel
healthi
blood
donor
need
screen
antibodi
r
rickettsii
infect
dog
acut
ill
subclin
carrier
state
known
exist
dog
seroposit
rickettsia
spp
need
exclud
blood
donor
west
nile
viru
wnv
zoonot
arboviru
genu
flaviviru
infect
human
asymptomat
mild
diseas
character
fever
headach
muscl
ach
skin
rash
meningoenceph
develop
case
although
dog
becom
virem
infect
wnv
typic
develop
subclin
viremia
low
magnitud
follow
clearanc
viru
rare
report
clinic
diseas
therefor
canin
blood
donor
need
test
cat
phagocytophilum
infect
develop
mild
clinic
ill
resolv
quickli
administr
research
cat
infest
scapulari
endem
area
becom
pcr
posit
seroconvers
develop
antibodi
detect
commerci
avail
assay
use
dog
sera
maintain
rickettsemia
week
administr
addit
cat
phagocytophilum
infect
morula
visual
cytolog
cytoplasm
organ
caus
ill
cat
transmit
experiment
blood
inocul
result
persist
infect
associ
ill
panel
recommend
optim
healthi
cat
endem
area
screen
phagocytophilum
infect
serolog
pcr
neg
test
tabl
howev
endem
area
seroposit
cat
may
common
limit
blood
donor
pool
thu
committe
believ
blood
donor
cat
phagocytophilum
seroneg
pcr
neg
avail
cat
phagocytophilum
seroposit
pcr
cultur
neg
could
use
tabl
infect
cat
plati
occasion
document
cat
live
area
endem
rhipicephalu
spp
tick
screen
pcr
tabl
number
bartonella
spp
grown
amplifi
blood
cat
commonli
b
hensela
b
clarridgeia
b
koehlera
b
cat
reservoir
ctenocephalid
feli
vector
b
hensela
b
clarridgeia
b
koehlera
agent
extrem
common
blood
cat
bartonella
hensela
appear
like
pathogen
studi
need
determin
diseas
associ
speci
bartonella
hensela
infect
document
pcr
assay
commun
sourc
cat
use
blood
donor
unit
state
like
reflect
use
flea
control
infect
cat
typic
prolong
subclin
bacteremia
number
clinic
sequela
also
bartonella
spp
transmit
blood
transfus
store
blood
inactiv
sensit
way
document
bartonella
spp
blood
cat
concurr
use
special
cultur
media
pcr
assay
use
sever
blood
although
approach
frequent
need
prove
presenc
bartonella
spp
blood
clinic
ill
dog
whether
increas
sensit
need
screen
cat
use
blood
donor
remain
proven
cat
definit
host
b
hensela
high
level
bacteremia
often
detect
even
cat
healthi
thu
broad
rang
pcr
assay
pcr
assay
use
specif
primer
use
wide
commerci
laboratori
unit
state
like
detect
infect
cat
tabl
bacteremia
cat
infect
b
hensela
exposur
infect
c
feli
preced
seroconvers
day
thu
serolog
alon
inadequ
screen
howev
immun
respons
develop
bacteremia
intermitt
cat
fals
neg
result
could
occur
singl
sampl
thu
panel
recommend
optim
standard
use
cat
seroneg
pcr
assay
cultur
neg
tabl
major
state
unit
state
endem
c
feli
bartonella
spp
seropreval
rate
high
thu
mani
state
requir
blood
donor
cat
bartonella
spp
seroneg
pcr
cultur
neg
could
make
difficult
find
adequ
number
donor
although
seroposit
mani
healthi
cat
infect
b
c
feli
limit
bacteremia
time
thu
panel
believ
minim
standard
use
bartonella
spp
pcr
neg
cat
tabl
use
antibiot
consist
elimin
bartonella
spp
infect
cat
thu
pcr
cultur
posit
cat
exclud
blood
donor
cytauxzoon
feli
tickborn
protozo
pathogen
order
piroplasmida
famili
theileriida
section
cytauxzoonosi
use
denot
acut
ill
ie
system
inflammatori
respons
syndrom
cytopenia
failur
associ
c
feli
infect
tick
transmiss
organ
undergo
schizogoni
myeloid
cell
specif
lineag
unknown
follow
merogoni
erythrocyt
schizogen
stage
associ
ill
diseas
transmit
experiment
transmiss
blood
cat
cytauxzoonosi
naiv
major
cat
cytauxzoonosi
present
veterinari
hospit
develop
sever
febril
ill
cytopenia
often
die
within
day
present
appropri
treatment
given
carrier
state
erythrocyt
infect
identifi
associ
clinic
fact
transfus
blood
chronic
infect
cat
naiv
cat
result
ill
theoret
risk
transmiss
cytauxzoonosi
exist
parasitemia
preced
ill
experiment
infect
parasit
dna
detect
earli
day
clinic
sign
begin
day
serolog
assay
avail
use
indoor
cat
receiv
appropri
ectoparasit
prophylaxi
advis
avoid
diseas
donor
anim
appropri
donor
select
physic
examin
minim
transmiss
risk
panel
recommend
optim
standard
use
pcr
neg
cat
endem
area
tabl
cat
clinic
sign
diseas
document
e
e
organ
dna
studi
evalu
e
cani
e
organ
healthi
cat
unit
state
yield
neg
thu
although
committe
believ
optim
cat
test
ehrlichia
spp
infect
screen
also
accept
tabl
hemoplasmosi
felin
infecti
anemia
caus
mycoplasma
haemof
speci
hemoplasma
infect
cat
north
america
candidatu
haemominutum
mhm
candidatu
turicensi
mtc
organ
substanti
less
pathogen
frequent
detect
preval
use
pcr
blood
pet
cat
either
appar
healthi
brought
veterinari
clinic
reason
contrast
north
america
haemof
rare
detect
cat
use
cat
chronic
infect
candidatu
haemominutum
splenectom
concurr
treat
high
dose
glucocorticoid
persist
subclin
infect
occur
absenc
although
flea
suggest
involv
transmiss
evid
transmiss
weak
epidemiolog
evid
suggest
aggress
interact
cat
may
lead
intraven
inocul
infect
blood
use
produc
experiment
serolog
assay
infect
commerci
avail
blood
smear
evalu
insensit
especi
chronic
carrier
cat
also
lack
specif
organ
easili
confus
stain
precipit
dri
artifact
thu
diagnost
test
choic
screen
blood
donor
pcr
pathogen
haemof
panel
agre
cat
test
haemof
test
posit
exclud
blood
donor
pool
optim
cat
test
candidatu
haemominutum
candidatu
turicensi
exclud
donor
pool
given
high
preval
organ
cat
popul
lack
strong
evid
associ
diseas
even
immunosuppress
cat
panel
agre
screen
pathogen
could
consid
option
posit
cat
could
use
donor
absenc
sourc
neg
blood
tabl
antimicrobi
therapi
reliabl
elimin
hemoplasma
appear
particularli
ineffect
treatment
candidatu
haemominutum
infect
panel
recommend
treat
potenti
donor
antimicrobi
attempt
elimin
infect
importantli
haemof
appear
inactiv
storag
whole
blood
candidatu
haemominutum
may
remain
viabl
blood
product
week
although
inactiv
appear
occur
month
storag
neorickettsia
risticii
infect
cat
experiment
inocul
detect
natur
expos
although
committe
believ
optim
cat
test
neorickettsia
risticii
infect
screen
also
accept
tabl
transmiss
felin
leukemia
viru
felv
occur
primarili
saliva
viru
present
blood
transmit
blood
screen
donor
cat
felv
use
elisa
detect
solubl
circul
core
viral
antigen
peripher
blood
recommend
cat
test
exclud
blood
donor
recognit
cat
expos
felv
develop
regress
infect
defin
transient
undetect
antigenemia
provir
dna
blood
optim
pcr
test
provir
dna
perform
felv
proviru
howev
pcr
assay
felv
provir
dna
current
avail
unit
state
evalu
clinic
sensit
specif
regressor
cat
detect
provir
dna
viral
rna
mani
tissu
includ
bone
marrow
mani
year
felv
exposur
indic
cat
complet
clear
regressor
cat
transmit
felv
infect
recipi
cat
blood
transfus
recipi
go
develop
progress
furthermor
reactiv
felv
infect
regressor
cat
without
immun
suppress
reactiv
regress
felv
infect
potenti
place
donor
cat
risk
hous
togeth
coloni
situat
reactiv
occur
interv
routin
screen
test
eg
annual
screen
detect
cat
constant
potenti
exposur
exclud
blood
donor
program
felin
immunodefici
viru
fiv
transmit
primarili
bite
wound
readili
transmit
via
inocul
infect
test
donor
cat
antibodi
elisa
use
immobil
fiv
core
protein
captur
antibodi
blood
recommend
seroposit
cat
exclud
donor
pool
cat
vaccin
fiv
also
seroposit
definit
differenti
infect
vaccin
cat
challeng
viru
isol
gold
standard
diagnosi
fiv
infect
expens
quantit
pcr
assay
fiv
moder
sensit
highli
specif
fiv
infect
posit
result
occur
uninfect
vaccin
therefor
reliabl
approach
avail
conclus
discrimin
natur
infect
cat
vaccin
cat
panel
recommend
seroposit
cat
includ
vaccin
cat
exclud
donor
pool
cat
also
exclud
donor
program
although
cat
subclin
infect
felin
coronaviru
document
transmiss
viru
blood
transfus
exist
time
screen
blood
donor
cat
serolog
revers
transcriptas
rt
recommend
healthi
cat
antibodi
titer
felin
coronaviru
also
posit
consensu
panel
screen
coronaviru
antibodi
rna
clinic
healthi
cat
consid
blood
donor
dog
recent
document
reservoir
agent
studi
fail
amplifi
r
feli
dna
blood
cat
thu
panel
recommend
screen
organ
cat
cat
definit
host
toxoplasma
gondii
intracellular
coccidian
parasit
although
toxoplasma
gondii
antigen
dna
detect
healthi
cat
pcr
assay
transmiss
blood
transfus
purpos
blood
safeti
consensu
panel
indic
screen
healthi
potenti
donor
cat
gondii
antigen
antibodi
dna
tabl
present
current
recommend
blood
donor
screen
consensu
panel
hope
find
lead
reevalu
current
infecti
diseas
screen
process
potenti
canin
felin
donor
diagnost
laboratori
reexamin
donor
screen
panel
offer
assay
pathogen
concern
diseas
transmiss
standard
form
tabl
complet
enrol
potenti
blood
donor
donationa
complet
histori
thorough
physic
examin
includ
determin
rectal
temperatur
donor
anim
complet
blood
collectionus
antimicrobi
drug
prevent
treat
possibl
infect
accept
substitut
laboratori
test
potenti
blood
donorsiniti
clinicopatholog
screen
potenti
donor
advis
eg
cbc
serum
biochemistri
urinalysi
fecal
examin
determin
pcv
advis
collect
blood
transfus
collect
asept
mannerbefor
administr
label
blood
product
examin
follow
collect
expir
date
donor
speci
product
type
blood
typebefor
administr
blood
product
visual
inspect
bacteri
contamin
suspect
bag
segment
appear
much
lighter
color
bag
red
blood
cell
mass
appear
purpl
zone
hemolysi
observ
red
cell
mass
clot
visibl
plasma
supernat
fluid
murki
purpl
brown
red
presenc
find
cultur
blood
perform
determin
whether
contamin
occur
unit
appear
abnorm
administeredcurr
screen
individu
unit
infecti
diseas
practic
veterinari
medicin
turnaround
time
cost
test
howev
model
consid
gold
standardan
aliquot
plasma
whole
blood
tube
segment
donat
unit
blood
store
practic
allow
retrospect
test
case
suspect
diseas
transmiss
record
kept
transfus
document
donor
unit
use
recipi
transfus
appropri
record
must
kept
recipi
receiv
blood
given
donor
easili
contact
donor
found
carri
infecti
diseas
agentdevelop
consent
form
detail
potenti
diseas
transmiss
risk
consid
owner
patient
receiv
transfus
thousand
blood
transfus
perform
year
dog
cat
demand
blood
product
continu
grow
risk
associ
transfus
includ
risk
diseas
transmiss
appropri
screen
blood
donor
infecti
diseas
agent
perform
decreas
risk
geograph
restrict
diseas
breed
predilect
document
actual
diseas
transmiss
transfus
factor
might
need
consid
make
decis
screen
program
use
addit
factor
involv
gener
health
care
manag
blood
donor
employ
ensur
blood
safeti
